| Literature DB >> 34130107 |
Daniel Ferreira1, Zuzana Nedelska2, Jonathan Graff-Radford3, Scott A Przybelski4, Timothy G Lesnick4, Christopher G Schwarz5, Hugo Botha3, Matthew L Senjem6, Julie A Fields7, David S Knopman3, Rodolfo Savica3, Tanis J Ferman8, Neill R Graff-Radford9, Val J Lowe5, Clifford R Jack5, Ronald C Petersen3, Afina W Lemstra10, Marleen van de Beek10, Frederik Barkhof11, Frederic Blanc12, Paulo Loureiro de Sousa12, Nathalie Philippi12, Benjamin Cretin12, Catherine Demuynck12, Jakub Hort13, Ketil Oppedal14, Bradley F Boeve3, Dag Aarsland15, Eric Westman16, Kejal Kantarci17.
Abstract
We investigated whether cerebrovascular disease contributes to neurodegeneration and clinical phenotype in dementia with Lewy bodies (DLB). Regional cortical thickness and subcortical gray matter volumes were estimated from structural magnetic resonance imaging (MRI) in 165 DLB patients. Cortical and subcortical infarcts were recorded and white matter hyperintensities (WMHs) were assessed. Subcortical only infarcts were more frequent (13.3%) than cortical only infarcts (3.1%) or both subcortical and cortical infarcts (2.4%). Infarcts, irrespective of type, were associated with WMHs. A higher WMH volume was associated with thinner orbitofrontal, retrosplenial, and posterior cingulate cortices, smaller thalamus and pallidum, and larger caudate volume. A higher WMH volume was associated with the presence of visual hallucinations and lower global cognitive performance, and tended to be associated with the absence of probable rapid eye movement sleep behavior disorder. Presence of infarcts was associated with the absence of parkinsonism. We conclude that cerebrovascular disease is associated with gray matter neurodegeneration in patients with probable DLB, which may have implications for the multifactorial treatment of probable DLB.Entities:
Keywords: Cerebrovascular disease; Dementia with Lewy bodies (DLB); Magnetic resonance imaging; Neurodegeneration; White matter hyperintensities; infarcts
Mesh:
Year: 2021 PMID: 34130107 PMCID: PMC8338792 DOI: 10.1016/j.neurobiolaging.2021.04.029
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 5.133